Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

411 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Post COVID-19 irritable bowel syndrome.
Marasco G, Cremon C, Barbaro MR, Cacciari G, Falangone F, Kagramanova A, Bordin D, Drug V, Miftode E, Fusaroli P, Mohamed SY, Ricci C, Bellini M, Rahman MM, Melcarne L, Santos J, Lobo B, Bor S, Yapali S, Akyol D, Sapmaz FP, Urun YY, Eskazan T, Celebi A, Kacmaz H, Ebik B, Binicier HC, Bugdayci MS, Yağcı MB, Pullukcu H, Kaya BY, Tureyen A, Hatemi İ, Koc ES, Sirin G, Calıskan AR, Bengi G, Alıs EE, Lukic S, Trajkovska M, Hod K, Dumitrascu D, Pietrangelo A, Corradini E, Simren M, Sjölund J, Tornkvist N, Ghoshal UC, Kolokolnikova O, Colecchia A, Serra J, Maconi G, De Giorgio R, Danese S, Portincasa P, Di Sabatino A, Maggio M, Philippou E, Lee YY, Salvi D, Venturi A, Borghi C, Zoli M, Gionchetti P, Viale P, Stanghellini V, Barbara G; GI-COVID19 study group. Marasco G, et al. Among authors: di sabatino a. Gut. 2022 Dec 9:gutjnl-2022-328483. doi: 10.1136/gutjnl-2022-328483. Online ahead of print. Gut. 2022. PMID: 36591612
Small Amounts of Gluten in Subjects With Suspected Nonceliac Gluten Sensitivity: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial.
Di Sabatino A, Volta U, Salvatore C, Biancheri P, Caio G, De Giorgio R, Di Stefano M, Corazza GR. Di Sabatino A, et al. Among authors: di stefano m. Clin Gastroenterol Hepatol. 2015 Sep;13(9):1604-12.e3. doi: 10.1016/j.cgh.2015.01.029. Epub 2015 Feb 19. Clin Gastroenterol Hepatol. 2015. PMID: 25701700 Clinical Trial.
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism.
Barbaro MR, Di Sabatino A, Cremon C, Giuffrida P, Fiorentino M, Altimari A, Bellacosa L, Stanghellini V, Barbara G. Barbaro MR, et al. Among authors: di sabatino a. Am J Physiol Gastrointest Liver Physiol. 2016 Mar 15;310(6):G439-47. doi: 10.1152/ajpgi.00368.2015. Epub 2016 Jan 7. Am J Physiol Gastrointest Liver Physiol. 2016. PMID: 26744473 Free article.
Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity.
Barbaro MR, Cremon C, Morselli-Labate AM, Di Sabatino A, Giuffrida P, Corazza GR, Di Stefano M, Caio G, Latella G, Ciacci C, Fuschi D, Mastroroberto M, Bellacosa L, Stanghellini V, Volta U, Barbara G. Barbaro MR, et al. Among authors: di sabatino a, di stefano m. Gut. 2020 Nov;69(11):1966-1974. doi: 10.1136/gutjnl-2019-319281. Epub 2020 Feb 14. Gut. 2020. PMID: 32060130
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population.
Maconi G, Bosetti C, De Monti A, Boyapati RK, Shelton E, Piazza N, Carvalhas Gabrielli AM, Lenti MV, Bezzio C, Ricci C, Greco S, Romeo S, Giangregorio F, Gridavilla D, Tagliani F, Massari A, Pastorelli L, Di Sabatino A, Saibeni S, Alicante S, Ferretti F, Rizzardini G, Galli M, Ardizzone S. Maconi G, et al. Among authors: di sabatino a. Dig Liver Dis. 2021 Mar;53(3):263-270. doi: 10.1016/j.dld.2020.12.013. Epub 2020 Dec 26. Dig Liver Dis. 2021. PMID: 33483259 Free PMC article.
Implications of SARS-CoV-2 infection for neurogastroenterology.
Marasco G, Lenti MV, Cremon C, Barbaro MR, Stanghellini V, Di Sabatino A, Barbara G. Marasco G, et al. Among authors: di sabatino a. Neurogastroenterol Motil. 2021 Mar;33(3):e14104. doi: 10.1111/nmo.14104. Epub 2021 Feb 16. Neurogastroenterol Motil. 2021. PMID: 33591607 Free PMC article. Review.
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy.
Ardizzone S, Ferretti F, Monico MC, Carvalhas Gabrielli AM, Carmagnola S, Bezzio C, Saibeni S, Bosani M, Caprioli F, Mazza S, Casini V, Cortelezzi CC, Parravicini M, Cassinotti A, Cosimo P, Indriolo A, Di Sabatino A, Lenti MV, Pastorelli L, Conforti F, Ricci C, Sarzi-Puttini P, Vecchi M, Maconi G. Ardizzone S, et al. Among authors: di sabatino a. J Gastroenterol Hepatol. 2021 Nov;36(11):3050-3055. doi: 10.1111/jgh.15591. Epub 2021 Jul 5. J Gastroenterol Hepatol. 2021. PMID: 34159648 Free PMC article.
Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility.
Savarino E, Zingone F, Barberio B, Marasco G, Akyuz F, Akpinar H, Barboi O, Bodini G, Bor S, Chiarioni G, Cristian G, Corsetti M, Di Sabatino A, Dimitriu AM, Drug V, Dumitrascu DL, Ford AC, Hauser G, Nakov R, Patel N, Pohl D, Sfarti C, Serra J, Simrén M, Suciu A, Tack J, Toruner M, Walters J, Cremon C, Barbara G. Savarino E, et al. Among authors: di sabatino a. United European Gastroenterol J. 2022 Jul;10(6):556-584. doi: 10.1002/ueg2.12259. Epub 2022 Jun 13. United European Gastroenterol J. 2022. PMID: 35695704 Free PMC article. Review.
411 results